Enzymotec Ltd
ENZY
ENZY was delisted on the 10th of January, 2018.
34 hedge funds and large institutions have $187M invested in Enzymotec Ltd in 2014 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 3 closing their positions.
367% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 3
140% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 5
72% more capital invested
Capital invested by funds: $109M → $187M (+$78.5M)
48% more funds holding
Funds holding: 23 → 34 (+11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Paulson & Co
New York
|
+$67.3M |
| 2 |
VAM
Visium Asset Management
New York
|
+$11.9M |
| 3 |
Millennium Management
New York
|
+$9.86M |
| 4 |
AP
Alydar Partners
Boston,
Massachusetts
|
+$5.87M |
| 5 |
PA
Perceptive Advisors
New York
|
+$5.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$14M |
| 2 |
Goldman Sachs
New York
|
-$351K |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$327K |
| 4 |
PCM
Prelude Capital Management
New York
|
-$270K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$185K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $250K | +$269K | +10,151 | +853% |
|
27
Morgan Stanley
New York
| $248K | -$18.4K | -695 | -6% |
|
28
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $165K | +$199K | +7,513 | New |
|
|
MTIP
29
Magee Thomson Investment Partners
San Diego,
California
| $119K | – | – | – |
|
30
Bank of America
Charlotte,
North Carolina
| $81K | +$78.9K | +2,975 | +418% |
|
|
U
31
UBS
Zurich,
Switzerland
| $36K | -$185K | -6,997 | -81% |
|
32
Citigroup
New York
| $8K | -$3.5K | -132 | -27% |
|
|
TRCT
33
Tower Research Capital (TRC)
New York
| $7K | +$1.54K | +58 | +21% |
|
34
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | +$3.98K | +150 | New |
|
|
35
Fidelity Investments
Boston,
Massachusetts
| – | -$14M | -519,189 | Closed |
|
|
BIT
36
BlackRock Institutional Trust
San Francisco,
California
| – | -$327K | -12,091 | Closed |
|
|
PCM
37
Prelude Capital Management
New York
| – | -$270K | -10,000 | Closed |
|
ENZY Hedge Fund Activity: Q1 2014 in Review
34 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q1 2014, worth a combined $187M — up 72% from $109M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ENZY positions and 3 closed out — a net gain of 11 holders — while 12 added to existing stakes and 5 trimmed.
The largest buyer was Paulson & Co, adding an estimated $67.3M. The largest seller was Fidelity Investments, exiting entirely with an estimated $14M sold.
- 34 institutional investors held Enzymotec Ltd (ENZY) as of Q1 2014, up from 23 in Q4 2013.
- Funds reported $187M of Enzymotec Ltd stock for Q1 2014, up 72% quarter-over-quarter.
- 14 funds opened new Enzymotec Ltd positions in Q1 2014 and 3 closed out, a net change of +11 holders.
- The largest Enzymotec Ltd buyer in Q1 2014 was Paulson & Co, an estimated $67.3M added.
- The largest Enzymotec Ltd seller in Q1 2014 was Fidelity Investments, an estimated $14M sold.
Based on aggregated 13F filings for Q1 2014.